Comparison of 36 Gy, 20 Gy or No Radiotherapy After Six Cycles of EBVP Chemotherapy and Complete Remission in Early Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORTC–GELA H9-F Intergroup Randomized Trial

While patients with early-stage Hodgkin lymphoma (HL) have an excellent outcome with combined treatment, radiotherapy dose and treatment with chemotherapy alone remain questionable. The noninferiority trial evaluates the feasibility of reducing the dose or omitting radiotherapy after chemotherapy.

http://ift.tt/2yVAGnR